Side effects of pain and analgesia in animal experimentation

Lab Animal

Volumn 46, Issue 4, 2017, Pages 123-128

  Jirkof, Paulin ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANTIPYRETIC AGENT; NARCOTIC ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT;

ADVERSE EFFECTS; ANALGESIA; ANIMAL; PAIN; RODENT; VETERINARY;

ANALGESIA; ANALGESICS; ANALGESICS, OPIOID; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIPYRETICS; PAIN; RODENTIA;

EID: 85016185154     PISSN: 00937355     EISSN: 15484475     Source Type: Journal    
DOI: 10.1038/laban.1216     Document Type: Review

References (73)

1. Pain terms: a list with defnitions and notes on usage. Recommended by the iASP Subcommittee on Taxonomy. Pain 6, 249 (1979).
2. Carbone, L. & Austin, J. Pain and laboratory animals: publication practices for better data reproducibility and better animal welfare. PLoS ONE 11, e0155001 (2016).
3. Purves, D., Augustine, G., Fitzpatrick, D. & Hall, W. Neuroscience, 4th edn. (Sinauer Associates, 2008).
4. Schwarz, C. et al. Mechanical load modulates the stimulatory effect of bmp2 in a rat nonunion model. Tissue Eng. Part A 19, 247-254 (2013).
5. Arras, M., Rettich, A., Cinelli, P., Kasermann, H.P. & Burki, K. Assessment of post-laparotomy pain in laboratory mice by telemetric recording of heart rate and heart rate variability. BMC Vet. Res. 3, 16 (2007).
6. Henke, J. & Erhardt, W. Schmerzmanagement beim Klein-und Heimtier (eNKe, Stuttgart, 2001).
7. Carstens, E. & Moberg, G.P. Recognizing pain and distress in laboratory animals. ILAR J. 41, 62-71 (2000).
8. Page, G.G. The immune-suppressive effects of pain. Adv. Exp. Med. Biol. 521, 117-125 (2003).
9. Jirkof, P. et al. Assessment of postsurgical distress and pain in laboratory mice by nest complexity scoring. Lab. Anim. 47, 153-161 (2013).
10. Jirkof, P. et al. Burrowing behavior as an indicator of post-laparotomy pain in mice. Front. Behav. Neurosci. 4, 165 (2010).
11. Jirkof, P., Cesarovic, N., Rettich, A., Fleischmann, T. & Arras, M. Individual housing of female mice: infuence on postsurgical behavior and recovery. Lab. Anim. 46, 325-334 (2012).
12. Mogil, J.S. et al. Heritability of nociception i: responses of 11 inbred mouse strains on 12 measures of nociception. Pain 80, 67-82 (1999).
13. Mogil, J.S. The genetic mediation of individual differences in sensitivity to pain and its inhibition. Proc. Natl. Acad. Sci. USA 96, 7744-7751 (1999).
14. Davidson, S., Truong, H. & Giesler, G.J. Jr. Quantitative analysis of spinothalamic tract neurons in adult and developing mouse. J. Comp. Neurol. 518, 3193-3204 (2010).
15. Bodnar, R.J. & Kest, B. Sex differences in opioid analgesia, hyperalgesia, tolerance and withdrawal: central mechanisms of action and roles of gonadal hormones. Horm. Behav. 58, 72-81 (2010).
16. Collins, D., Reed, B., Zhang, Y. & Kreek, M.J. Sex differences in responsiveness to the prescription opioid oxycodone in mice. Pharmacol Biochem. Behav. 148, 99-105 (2016).
17. Cinelli, P., Rettich, A., Seifert, B., Burki, K. & Arras, M. Comparative analysis and physiological impact of different tissue biopsy methodologies used for the genotyping of laboratory mice. Lab. Anim. 41, 174-184 (2007).
18. Moberg, G.P. When does stress become distress? Lab Anim. (NY) 28, 22-26 (1999).
19. Jirkof, P., Tourvieille, A., Cinelli, P. & Arras, M. Buprenorphine for pain relief in mice: repeated injections vs sustained-release depot formulation. Lab. Anim. 49, 177-187 (2015).
20. Foley, P.L., Liang, H. & Crichlow, A.R. Evaluation of a sustained-release formulation of buprenorphine for analgesia in rats. J. Am. Assoc. Lab. Anim. Sci. 50, 198-204 (2011).
21. Liles, J.H., Flecknell, P.A., Roughan, J. & Cruz-Madorran, I. Infuence of oral buprenorphine, oral naltrexone or morphine on the effects of laparotomy in the rat. Lab. Anim. 32, 149-161 (1998).
22. Goldkuhl, R., Jacobsen, K.R., Kalliokoski, O., Hau, J. & Abelson, K.S. Plasma concentrations of corticosterone and buprenorphine in rats subjected to jugular vein catheterization. Lab. Anim. 44, 337-343 (2010).
23. Molina-Cimadevila, M.J. et al. Oral self-administration of buprenorphine in the diet for analgesia in mice. Lab. Anim. 48, 216-224 (2014).
24. Sauer, M., Fleischmann, T., Lipiski, M., Arrasa, M. & Jirkof, P. Buprenorphine via drinking water and combined oral-injection protocols for pain relief in mice. Appl. Anim. Behav. Sci. 185, 103-112 (2016).
25. Thompson, A.C., DiPirro, J.M., Sylvester, A.R., Martin, L.B. & Kristal, M.B. Lack of analgesic effcacy in female rats of the commonly recommended oral dose of buprenorphine. J. Am. Assoc. Lab. Anim. Sci. 45, 13-16 (2006).
26. Brewster, D., Humphrey, M.J. & Mcleavy, M.A. The systemic bioavailability of buprenorphine by various routes of administration. J. Pharm. Pharmacol. 33, 500-506 (1981).
27. Dahl, J.B. Pre-emptive analgesia. Lancet 342, 561-562 (1993).
28. Williams, J.T. et al. Regulation of mu-opioid receptors: desensitization, phosphorylation, internalization, and tolerance. Pharmacol. Rev. 65, 223-254 (2013).
29. Sehgal, N., Smith, H.S. & Manchikanti, L. Peripherally acting opioids and clinical implications for pain control. Pain Physician 14, 249-258 (2011).
30. Aronson, J. Meyler's Side Effects of Analgesics and Anti-infammatory Drugs. 1st edn. (elsevier, 2010).
31. Rivat, C. & Ballantyne, J. The dark side of opioids in pain management: basic science explains clinical observation. PAIN Rep. 1, e570 (2016).
32. King, T., Ossipov, M.H., Vanderah, T.W., Porreca, F. & Lai, J. Is paradoxical pain induced by sustained opioid exposure an underlying mechanism of opioid antinociceptive tolerance? Neurosignals 14, 194-205 (2005).
33. Wala, E.P. & Holtman, J.R. Jr. Buprenorphine-induced hyperalgesia in the rat. Eur. J. Pharmacol. 651, 89-95 (2011).
34. Lyons, P.J., Rivosecchi, R.M., Nery, J.P. & Kane-Gill, S.L. Fentanyl-induced hyperalgesia in acute pain management. J. Pain Palliat. Care Pharmacother. 29, 153-160 (2015).
35. Lee, S.H. et al. Tramadol induced paradoxical hyperalgesia. Pain Physician 16, 41-44 (2013).
36. Crain, S.M. & Shen, K.F. Acute thermal hyperalgesia elicited by low-dose morphine in normal mice is blocked by ultra-low-dose naltrexone, unmasking potent opioid analgesia. Brain Res. 888, 75-82 (2001).
37. Sacerdote, P. Opioid-induced immunosuppression. Curr. Opin. Support. Palliat. Care 2, 14-18 (2008).
38. Al-Hashimi, M., Scott, S.W., Thompson, J.P. & Lambert, D.G. Opioids and immune modulation: more questions than answers. Br. J. Anaesth. 111, 80-88 (2013).
39. Xia, M. et al. Tramadol inhibits proliferation, migration and invasion via alpha2-adrenoceptor signaling in breast cancer cells. Eur. Rev. Med. Pharmacol. Sci. 20, 157-165 (2016).
40. Zhang, X.L., Chen, M.L. & Zhou, S.L. Fentanyl inhibits proliferation and invasion of colorectal cancer via beta-catenin. Int. J. Clin. Exp. Pathol. 8, 227-235 (2015).
41. Sasamura, T. et al. Morphine analgesia suppresses tumor growth and metastasis in a mouse model of cancer pain produced by orthotopic tumor inoculation. Eur. J. Pharmacol. 441, 185-191 (2002).
42. Bimonte, S. et al. Morphine promotes tumor angiogenesis and increases breast cancer progression. Biomed Res. Int. 2015, 161508 (2015).
43. Tanaka, K., Kersten, J.R. & Riess, M.L. Opioid-induced cardioprotection. Curr. Pharm. Des. 20, 5696-5705 (2014).
44. Xu, Y.C. et al. Kappa-Opioid receptors are involved in enhanced cardioprotection by combined fentanyl and limb remote ischemic postconditioning. J. Anesth. 29, 535-543 (2015).
45. Brennan, M.J. The effect of opioid therapy on endocrine function. Am. J. Med. 126 Suppl 1, S12-S18 (2013).
46. Goulding, D.R. et al. The effects of perioperative analgesia on litter size in Crl:CD1(iCR) mice undergoing embryo transfer. J. Am. Assoc. Lab. Anim. 49, 423-426 (2010).
47. Van der Schier, R., Roozekrans, M., Van velzen, M., Dahan, A. & Niesters, M. Opioid-induced respiratory depression: reversal by non-opioid drugs. F1000Prime Rep. 6, 79 (2014).
48. Mcintyre, M.K., Clifford, J.L., Maani, C.V. & Burmeister, D.M. Progress of clinical practice on the management of burn-associated pain: lessons from animal models. Burns 42, 1161-1172 (2016).
49. Bomzon, A. Are repeated doses of buprenorphine detrimental to postoperative recovery after laparotomy in rats? Comp. Med. 56, 114-118 (2006).
50. Webster, L.R., Camilleri, M. & Finn, A. Opioid-induced constipation: rationale for the role of norbuprenorphine in buprenorphine-treated individuals. Subst. Abuse. Rehabil. 7, 81-86 (2016).
51. Clark, J.A., Myers, P.H., Goelz, M.F., Thigpen, J.E. & Forsythe, D.B. Pica behavior associated with buprenorphine administration in the rat. Lab. Anim. Sci. 47, 300-303 (1997).
52. Takeda, N., Hasegawa, S., Morita, M. & Matsunaga, T. Pica in rats is analogous to emesis: an animal-model in emesis research. Pharmacol. Biochem. Behav. 45, 817-821 (1993).
53. Johnson, R.A. Voluntary running-wheel activity, arterial blood gases, and thermal antinociception in rats after 3 buprenorphine formulations. J. Am. Assoc. Lab. Anim. Sci. 55, 306-311 (2016).
54. Mathiesen, O. et al. Adverse effects of perioperative paracetamol, NSAiDs, glucocorticoids, gabapentinoids and their combinations: a topical review. Acta Anaesthesiol. Scand. 58, 1182-1198 (2014).
55. Wickerts, L, warren Stomberg, M., Brattwall, M. & Jakobsson, J. Coxibs: is there a beneft when compared to traditional non-selective NSAiDs in postoperative pain management? Minerva Anestesiol. 77, 1084-1098 (2011).
56. Umar, A., Steele, V.E., Menter, D.G. & Hawk, E.T. Mechanisms of nonsteroidal anti-infammatory drugs in cancer prevention. Semin. Oncol. 43, 65-77 (2016).
57. Xin, B., Yokoyama, Y., Shigeto, T., Futagami, M. & Mizunuma, H. Inhibitory effect of meloxicam, a selective cyclooxygenase-2 inhibitor, and ciglitazone, a peroxisome proliferator-activated receptor gamma ligand, on the growth of human ovarian cancers. Cancer 110, 791-800 (2007).
58. Jiang, X. et al. Combining kallistatin gene therapy and meloxicam to treat hepatocellular carcinoma in mice. Cancer Sci. 100, 2226-2233 (2009).
59. Husmann, K. et al. Primary tumor growth in an orthotopic osteosarcoma mouse model is not infuenced by analgesic treatment with buprenorphine and meloxicam. Lab. Anim. 49, 284-293 (2015).
60. Parker, J.M., Austin, J., Wilkerson, J. & Carbone, L. Effects of multimodal analgesia on the success of mouse embryo transfer surgery. J. Am. Assoc. Lab. Anim. Sci. 50, 466-470 (2011).
61. Lim, H. et al. Multiple female reproductive failures in cyclooxygenase 2-defcient mice. Cell 91, 197-208 (1997).
62. Pountos, I., Georgouli, T., Calori, G.M. & Giannoudis, P.V. Do nonsteroidal anti-infammatory drugs affect bone healing? A critical analysis. ScientifcWorldJournal 2012, 606404 (2012).
63. Chen, M.R. & Dragoo, J.L. The effect of nonsteroidal anti-infammatory drugs on tissue healing. Knee Surg. Sports Traumatol. Arthrosc. 21, 540-549 (2013).
64. Krischak, G.D., Augat, P., Claes, L., Kinzl, L. & Beck, A. The effects of non-steroidal anti-infammatory drug application on incisional wound healing in rats. J. Wound Care 16, 76-78 (2007).
65. Ji, C. et al. Effect of non-steroidal anti-infammatory drugs on the increasing the incidence of colonic anastomosis in rats. Int. J. Clin. Exp. Pathol. 8, 6126-6134 (2015).
66. Smith, H.S. Perioperative intravenous acetaminophen and NSAiDs. Pain Med. 12, 961-981 (2011).
67. McNicol, E.D., Ferguson, M.C., Haroutounian, S., Carr, D.B. & Schumann, R. Single dose intravenous paracetamol or intravenous propacetamol for postoperative pain. Cochrane Database Syst. Rev. (5); CD007126 (2016).
68. Schug, S.A. Combination analgesia in 2005: a rational approach: focus on paracetamol-tramadol. Clin. Rheumatol. 25 Suppl 1, S16-S21 (2006).
69. Cannon, C.Z., Kissling, G.E., Goulding, D.R., King-Herbert, A.P. & Blankenship-Paris, T. Analgesic effects of tramadol, carprofen or multimodal analgesia in rats undergoing ventral laparotomy. Lab Anim. (NY) 40, 85-93 (2011).
70. Fernández-Dueñas, V. et al. Fentanyl-trazodone-paracetamol triple drug combination: multimodal analgesia in a mouse model of visceral pain. Pharmacol. Biochem. Behav. 98, 331-336 (2011).
71. Fishbain, D. Evidence-based data on pain relief with antidepressants. Ann. Med. 32, 305-316 (2000).
72. Mitra, R. & Jones, S. Adjuvant analgesics in cancer pain: a review. Am. J. Hosp. Palliat. Care. 29, 70-79 (2012).
73. Golledge, H. & Jirkof, P. Score sheets and analgesia. Lab. Anim. 50, 411-413 (2016).